前列腺SBRT中CBCT评估分次间与分次内运动的技术报告
该前瞻性技术报告纳入8例植入透明质酸间隔物并接受前列腺SBRT(37.5Gy/5次)的患者,用CBCT评估分次间和分次内前列腺位移及膀胱直肠体积变化。发现前列腺位置变异较大,匹配金标所需的床位移常超过CTV/PTV margin(0.4cm),分次内膀胱体积轻度增加但OAR体积变化与前列腺位移不相关。作者建议每个弧前进行kV金标成像,仅第一个弧前需一次CBCT,分次内OAR成像不必要。
要点
- 前列腺位置变异大,匹配金标所需床位移常超过0.4cm的CTV/PTV margin。
- 每个弧前kV金标成像是必需的,仅第一个弧前需一次CBCT。
- 分次内OAR成像不必要,OAR体积变化与前列腺位移不相关。
核心结论
- 前列腺位置变异较大,每个弧前kV金标成像似乎为必需,分次内OAR成像不必要,仅第一个弧前需一次CBCT。
研究设计与样本
- 前瞻性收集2015至2019年连续接受前列腺SBRT的患者数据,共纳入8例,用CBCT评估分次间和分次内前列腺位移及OAR体积变化。
主要发现
- 分次间膀胱体积变化不显著,分次内膀胱体积平均增加29cc且显著(p<0.001)。
- 分次间和分次内直肠体积变化除一例外均不显著,该例无直肠毒性。
- 匹配前列腺金标所需床位移幅度在第一个弧前(35%)和第二个弧前(15%)常超过CTV/PTV margin(0.4cm)。
- 分次间和分次内膀胱及直肠体积变化与前列腺位移不相关。
关键数值与推荐
- 前列腺SBRT剂量为37.5Gy,分5次,每次7.5Gy,以前列腺金标引导。
- CTV/PTV margin为0.4cm。
- 分次内膀胱体积平均增加29cc(p<0.001)。
临床怎么用
- 每个弧前应进行kV金标成像以校正前列腺位置。
- 仅第一个弧前需进行一次CBCT,分次内无需对OAR进行成像。
局限性
- 样本量仅8例,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In most clinical trials, gold fiducial markers are implanted in the prostate to tune the table position before each radiation beam. Yet, it is unclear if a cone-beam computed tomography (CBCT) should be performed before each beam to monitor a possible variation of the organs at risk (OARs) fullness, especially in case of recto-prostatic spacer implantation. The present study aimed at assessing the inter- and intra-fraction movements of prostate, bladder and rectum in patients implanted with a hyaluronic acid spacer and undergoing prostate stereotactic body radiotherapy (SBRT). METHODS: Data about consecutive patients undergoing prostate SBRT were prospectively collected between 2015 and 2019. Inter-and intra-fraction prostate displacements and volume variation of organs at risk (OARs) were assessed with CBCTs. RESULTS: Eight patients were included. They underwent prostate SBRT (37.5Gy, 5 fractions of 7.5Gy) guided by prostate gold fiducial markers. Inter-fraction variation of the bladder volume was insignificant. Intra-fraction mean increase of the bladder volume was modest (29 cc) but significant (p < 0.001). Both inter- and intra-fraction variations of the rectum volume were insignificant but for one patient. He had no rectal toxicity. The magnitude of table displacement necessary to match the prostate gold fiducial marker frequently exceeded the CTV/PTV margins (0.4 cm) before the first (35%) and the second arc (15%). Inter- and intra-fraction bladder and rectum volume variations did not correlate with prostate displacement. CONCLUSION: Major prostate position variations were reported. In-room kV fiducial imaging before each arc seems mandatory. Intra-fraction imaging of the OARs appears unnecessary. We suggest that only one CBCT is needed before the first arc. TRIAL REGISTRATION: NCT02361515, February 11th, 2015.
引用
- Jmour O, Benna M, Champagnol P, et al. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note. Radiat Oncol. 2020. PMID: 32307017. doi:10.1186/s13014-020-01534-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。